[go: up one dir, main page]

FI950302L - Förfarande för att öka kreatinförråd - Google Patents

Förfarande för att öka kreatinförråd Download PDF

Info

Publication number
FI950302L
FI950302L FI950302A FI950302A FI950302L FI 950302 L FI950302 L FI 950302L FI 950302 A FI950302 A FI 950302A FI 950302 A FI950302 A FI 950302A FI 950302 L FI950302 L FI 950302L
Authority
FI
Finland
Prior art keywords
increasing creatine
stores
creatine stores
increasing
creatine
Prior art date
Application number
FI950302A
Other languages
English (en)
Finnish (fi)
Other versions
FI950302A0 (sv
Inventor
Eric Hultman
Roger Harris
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10719231&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI950302(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of FI950302L publication Critical patent/FI950302L/sv
Publication of FI950302A0 publication Critical patent/FI950302A0/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI950302A 1992-07-24 1995-01-24 Förfarande för att öka kreatinförråd FI950302A0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929215746A GB9215746D0 (en) 1992-07-24 1992-07-24 A method of increasing creatine supply depot
PCT/SE1993/000631 WO1994002127A1 (en) 1992-07-24 1993-07-15 A method of increasing creatine supply depot

Publications (2)

Publication Number Publication Date
FI950302L true FI950302L (sv) 1995-01-24
FI950302A0 FI950302A0 (sv) 1995-01-24

Family

ID=10719231

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950302A FI950302A0 (sv) 1992-07-24 1995-01-24 Förfarande för att öka kreatinförråd

Country Status (9)

Country Link
US (1) US5767159A (sv)
EP (1) EP0652748A1 (sv)
JP (1) JPH07509230A (sv)
AU (1) AU678559B2 (sv)
CA (1) CA2140768C (sv)
FI (1) FI950302A0 (sv)
GB (1) GB9215746D0 (sv)
NZ (1) NZ254307A (sv)
WO (1) WO1994002127A1 (sv)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3213666B2 (ja) * 1994-02-28 2001-10-02 治彦 末岡 クレアチン飲料の製造方法
IT1271687B (it) * 1994-08-04 1997-06-04 Flamma Spa Sali organici idrosolubili della creatina
GB9517443D0 (en) * 1994-12-17 1995-10-25 Univ Nottingham Increasing creatine and glycogen concentration in muscle
DE19537494C2 (de) * 1995-09-25 1997-10-02 Desitin Arzneimittel Gmbh Kreatin zum Schutz von neuralem Gewebe
GB9611356D0 (en) * 1996-05-31 1996-08-07 Howard Alan N Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
US8128955B2 (en) * 1996-05-31 2012-03-06 The Original Creatine Patent Company Food compositions containing creatine
US6168802B1 (en) 1996-05-31 2001-01-02 The Howard Foundation Compositions containing creatine and aloe vera extract
US7150880B2 (en) 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US6274161B1 (en) 1996-05-31 2001-08-14 The Howard Foundation Compositions containing creatine in suspension
US6524611B2 (en) 1996-05-31 2003-02-25 The Howard Foundation Compositions containing creatine and creatinine
WO1998000148A1 (de) * 1996-06-28 1998-01-08 Ipr-Institute For Pharmaceutical Research Ag Arzneimittelzubereitungen, enthaltend kreatin mit mindestens einem salz von calcium, magnesium, mangan oder zink
US7504376B2 (en) 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
US5965596A (en) 1997-08-12 1999-10-12 Harris; Roger Methods and compositions for increasing the anaerobic working capacity in tissue
GB9616910D0 (en) * 1996-08-12 1996-09-25 Dunnett Mark A method of increasing ›-alanylihistidine pipetide synthesis and accumulation in humans and animals
IT1298420B1 (it) * 1996-11-19 2000-01-05 Monsanto It Spa Uso della creatina nell'insufficienza cardio-respiratoria
EP0894083B1 (de) * 1996-12-20 1999-11-03 SKW Trostberg Aktiengesellschaft Kreatin-pyruvate und verfahren zu deren herstellung
DE19653225A1 (de) * 1996-12-20 1998-06-25 Sueddeutsche Kalkstickstoff Kreatin-pyruvate und Verfahren zu deren Herstellung
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
JP3384539B2 (ja) * 1997-09-05 2003-03-10 義之 内田 喘息治療剤
WO1999021565A1 (en) 1997-10-24 1999-05-06 Cornell Research Foundation, Inc. Nutritional supplement for cerebral metabolic insufficiencies
US5973005A (en) * 1998-02-26 1999-10-26 Bio-Bontanica, Inc. Aqueous creatine solution and process of producing a stable, bioavailable aqueous creatine solution
US6218366B1 (en) 1998-06-19 2001-04-17 Bioenergy, Inc. Method for raising the hypoxic threshold
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6429198B1 (en) 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
US20020119933A1 (en) 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6534480B2 (en) 1999-06-17 2003-03-18 Bioenergy Inc. Compositions for increasing energy in vivo
US6294579B1 (en) 1999-10-11 2001-09-25 Joseph W. Carnazzo Method for improving delivery of tyrosine supplementation
US6703370B1 (en) 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
US20030212136A1 (en) 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
EP1324760B1 (en) * 2000-09-14 2007-06-20 Board of Regents of the University of Nebraska Creatine ester pronutrient compounds and formulations
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20030013767A1 (en) * 2001-07-13 2003-01-16 Samuel Bessman Method of treating weight loss using creatine
EP1536781B1 (en) * 2002-06-19 2010-02-17 N.V. Nutricia Nutritional or pharmaceutical compositions for increasing the creatine response of organisms
GB0518579D0 (en) * 2005-09-12 2005-10-19 Cr Technologies Llp Controlled delivery creatine formulations and method of using the same
DK3081215T3 (da) 2005-05-23 2020-04-27 Natural Alternatives Int Inc Sammensætninger og fremgangsmåder til langvarig frigørelse af beta-alanin
US7858599B2 (en) * 2005-12-30 2010-12-28 Hander Robert W Enhancement of urogenital function
JP2009527504A (ja) * 2006-02-23 2009-07-30 イオメディックス スリープ インターナショナル エスアールエル 良質な睡眠の誘導および維持のための組成物および方法
EP2027782A1 (en) * 2007-08-15 2009-02-25 Nestec S.A. Increasing the efficiency of utilization of ingested creatine
EP2098124A1 (en) 2008-03-03 2009-09-09 Nestec S.A. Carbohydrate gel
EP2269980A4 (de) 2008-12-24 2011-05-18 Vertex Closed Joint Stock Company Creatinamide, verfahren zu ihrer herstellung und wirkstoff zur ausführung einer neuroprotektiven aktion
RU2428414C2 (ru) 2009-11-03 2011-09-10 Закрытое Акционерное Общество "Вертекс" Способ получения амидов креатина
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
WO2017075289A1 (en) 2015-10-27 2017-05-04 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
US10821123B2 (en) 2016-02-01 2020-11-03 Bioenergy Life Science, Inc. Use of ribose for treatment of subjects having congestive heart failure
US11246846B2 (en) 2017-10-23 2022-02-15 Michael S. Tempesta Trisodium citrate compositions having enhanced uptake across digestive mucosa

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244534B1 (sv) * 1973-06-27 1977-07-01 Biotherax Lab
IT1214598B (it) * 1985-04-17 1990-01-18 Schiapparelli Farma Uso terapeutico della fosfocreatina.
IT1191639B (it) * 1985-11-11 1988-03-23 Schiapparelli Farma Composizione farmaceutica contenente fosfocreatina e metodo per preparla
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US5077313A (en) * 1988-11-25 1991-12-31 Gert Lubec Process for inhibiting pathological collagen cross-linking in diabetes patients
IT1237519B (it) * 1989-11-27 1993-06-08 Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
IT1240336B (it) * 1990-03-21 1993-12-07 Setra Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
US5308627A (en) * 1990-08-07 1994-05-03 Umbdenstock Jr Anthony J Nutritional supplement for optimizing cellular health
US5091404A (en) * 1990-10-05 1992-02-25 Elgebaly Salwa A Method for restoring functionality in muscle tissue
US5397786A (en) * 1993-01-08 1995-03-14 Simone; Charles B. Rehydration drink

Also Published As

Publication number Publication date
GB9215746D0 (en) 1992-09-09
EP0652748A1 (en) 1995-05-17
FI950302A0 (sv) 1995-01-24
JPH07509230A (ja) 1995-10-12
CA2140768C (en) 1999-12-07
US5767159A (en) 1998-06-16
CA2140768A1 (en) 1994-02-03
AU678559B2 (en) 1997-06-05
AU4594893A (en) 1994-02-14
NZ254307A (en) 1996-12-20
WO1994002127A1 (en) 1994-02-03

Similar Documents

Publication Publication Date Title
FI950302L (sv) Förfarande för att öka kreatinförråd
FI951596L (sv) Förfarande för erhållande av 10-desacetylbakkatin III
FI956135A0 (sv) Separeringsförfarande
FI931736A0 (fi) Biodegraderbart tgf-b-leveranssystem foer benregeneration
FI962069L (sv) Förfarande för framställning av karpolaktam
DE69329610D1 (de) Zugriffsverfahren
FI932108L (sv) Foerfarande foer fraktionering av sulfitavlut
FI954423L (sv) Förfarande för rening av taxoider
DE69414001D1 (de) Bestimmungsmethode
FI945636A0 (sv) Förfarande för rening av laktid
NO921218D0 (no) Reseptor-rensemetode
FI925357L (sv) Byggnadsförfarande
FI921621L (fi) Sprutmetod foer braensle
DE69332164D1 (de) Anodische Verbindungsverfahren
FI955800L (sv) Metod att framställa aminoalkylguanidiner
FI955710L (sv) Förfarande för bestämning av salmonella
FI931850L (sv) Foerfarande foer framstaellning av en mellanprodukt
DK96392D0 (da) Modifikationsmetode
FI933816L (fi) Understaell foer raelsfordon
NO941655D0 (no) Fremgangsmåte for detektering av sulfider
EE9400450A (et) Meetod detailide töötlemiseks
FI952134L (sv) Förfarande för framställning av alkylbenzen
FI931051A0 (sv) Avbildningsförfarande
DK64192D0 (da) Separationsmetode
LV10228A (lv) Tricinkadekaborata iegusanas metode

Legal Events

Date Code Title Description
FD Application lapsed